Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.568 | 3.27% | ||
CN¥0.568 | 3.27% | ||
CN¥0.55 | 10% | ||
CN¥0.55 | 10% | ||
CN¥0.50 | 66.67% | ||
CN¥0.30 | 7.91% | ||
CN¥0.278 | 20.87% | ||
CN¥0.23 | 76.92% | ||
CN¥0.13 | 85.71% | ||
CN¥0.07 | 0% | ||
CN¥0.07 | 7.69% | ||
CN¥0.065 | -50% | ||
CN¥0.13 | 85.71% |
Hangzhou Tigermed Consulting Co Ltd Class A pays a dividend yield (FWD) of 0.91%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €8.07
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Earnings Date
- Within the last 12 months, Hangzhou Tigermed Consulting Co Ltd Class A paid a dividend of CN¥0.57. For the next 12 months, Hangzhou Tigermed Consulting Co Ltd Class A is expected to pay a dividend of CN¥0.57. This corresponds to a dividend yield of approximately 0.91%.
- The dividend yield of Hangzhou Tigermed Consulting Co Ltd Class A is currently 0.91%.
- Hangzhou Tigermed Consulting Co Ltd Class A pays annually dividends. Payout is in July.
- The next dividend for Hangzhou Tigermed Consulting Co Ltd Class A is expected in July.
- Hangzhou Tigermed Consulting Co Ltd Class A paid dividend every year within the last 10 years.
- Dividends of CN¥0.57 are expected for the next 12 months. This corresponds to a dividend yield of 0.91%.
- Hangzhou Tigermed Consulting Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Hangzhou Tigermed Consulting Co Ltd Class A was on 1 July 2019 in the ratio 2:1.
- To receive the last dividend of Hangzhou Tigermed Consulting Co Ltd Class A on 12 July 2024 in the amount of CN¥0.57 you had to have the stock in your portfolio before the ex-day on 12 July 2024.
- The last dividend was paid on 12 July 2024.
- In 2022, dividends of CN¥0.50 were paid by Hangzhou Tigermed Consulting Co Ltd Class A.
- Dividends from Hangzhou Tigermed Consulting Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Hangzhou Tigermed Consulting Co Ltd Class A is located in China.